Home
Forms Library
Application to Market a New Drug, Biologic, or an Antibiotic Drug for Human Use Form FDA 356h

Application to Market a New Drug, Biologic, or an Antibiotic Drug for Human Use Form FDA 356h 2025

Application to Market a New Drug, Biologic, or an Antibiotic Drug for Human Use Form FDA 356h Preview on Page 1

Show details

4.3 out of 5

37 votes

The document is an OMB Information Collection Supporting Statement for Form FDA 356h, which is used by manufacturers to apply for the marketing of new drugs, biologics, or antibiotics for human use. It outlines the justification for the information collection, including the legal authority, purpose, and necessity of the data required by the FDA to ensure drug safety and efficacy. The document also discusses efforts to reduce burden through electronic submissions, the impact on small businesses, and provides estimates of annual reporting burdens and costs associated with this information collection.

Here's how it works

01. Edit your form online

Type text, add images, blackout confidential details, add comments, highlights and more.

02. Sign it in a few clicks

Draw your signature, type it, upload its image, or use your mobile device as a signature pad.

03. Share your form with others

Send it via email, link, or fax. You can also download it, export it or print it out.

How to quickly redact Application to Market a New Drug, Biologic, or an Antibiotic Drug for Human Use Form FDA 356h online

Ease of Setup

DocHub User Ratings on G2

Ease of Use

DocHub User Ratings on G2

Dochub is a perfect editor for modifying your forms online. Adhere to this simple guide to edit Application to Market a New Drug, Biologic, or an Antibiotic Drug for Human Use Form FDA 356h in PDF format online free of charge:

Register and log in. Register for a free account, set a secure password, and go through email verification to start managing your templates.
Upload a document. Click on New Document and choose the file importing option: add Application to Market a New Drug, Biologic, or an Antibiotic Drug for Human Use Form FDA 356h from your device, the cloud, or a protected URL.
Make adjustments to the sample. Take advantage of the top and left panel tools to redact Application to Market a New Drug, Biologic, or an Antibiotic Drug for Human Use Form FDA 356h. Insert and customize text, images, and fillable fields, whiteout unneeded details, highlight the significant ones, and provide comments on your updates.
Get your paperwork accomplished. Send the form to other people via email, create a link for faster file sharing, export the sample to the cloud, or save it on your device in the current version or with Audit Trail added.

Discover all the advantages of our editor today!

be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.

What is the purpose of the FDA form?

The Form FDA 483 notifies the companys management of observed objectionable conditions. At the conclusion of an inspection, the Form FDA 483 is presented and discussed with the companys senior management.

How to fill 356h form?

How to fill out the Form FDA 356h Instructions for Submissions? Enter the date of submission in Field 1. Fill out applicant information in Fields 2-6. Provide product details in Fields 7-15. Select the appropriate submission type in Fields 21-23. Review the form for completeness before submission.

Which form FDA is used for new drug application field report?

Applicants holding NDAs or ANDAs regulated by the Center for Drug Evaluation and Research (CDER) or the Center for Biologics Evaluation and Research (CBER) may use Form FDA 3331a, which is available on FDAs Field Alert Reports website,7 to submit FARs.

What is an application submitted to the FDA for permission to market a new biologic product in the US?

The Biologics License Application (BLA) is a request for permission to introduce, or deliver for introduction, a biologic product into interstate commerce (21 CFR 601.2). The BLA is regulated under 21 CFR 600 680.

What is the new drug application FDA process?

The drug sponsor formally asks FDA to approve a drug for marketing in the United States by submitting an NDA. An NDA includes all animal and human data and analyses of the data, as well as information about how the drug behaves in the body and how it is manufactured.

What are the other 3 forms used for the submission of the FDA for a NDA?

Form FDA 1571 is used for two purposes: 1) to obtain agreement from the sponsor (or sponsor-investigator) to conduct research ing to all appropriate FDA regulations; and 2) to serve as a cover sheet for all submissions to the FDA on behalf of a particular IND.

What is the FDA form 356h used for?

To apply to market a new drug, biologic, or an antibiotic drug for human use, you need to complete Form 356h. Form 356h includes information such as applicant information, proposed indication, establishment information, and more.

Application to Market a New Drug, Biologic, or an Antibiotic Drug for Human Use Form FDA 356h 2025

Here's how it works